Loading...
NPI 1093459836 · Wichita, KS · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Labcorp Kansas, Inc. is a clinical medical laboratory provider located in Wichita, Kansas. This profile covers 246 Medicare and 139 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Labcorp Kansas, Inc. |
| Address | 2916 E Central Ave |
| City | Wichita |
| State | KS |
| ZIP | 67214 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | April 27, 2022 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $2.1M |
| Medicaid | $1.3M |
LABCORP KANSAS, INC. reports materially larger Medicare receipts than Medicaid with Total Medicare revenue of $2.1M versus Total Medicaid revenue of $1.3M, indicating a payer mix weighted toward Medicare but with meaningful Medicaid volume. Both payer streams are substantive enough to shape operational priorities rather than representing a single-payer specialty lab.
The provider’s CPT mix is consistent with a broad clinical medical laboratory performing routine chemistry, hematology, endocrine, and infectious-disease assays: high-revenue Medicare codes include 80053 (CMP), 85025 (CBC) and 84443 (TSH), while Medicaid top codes emphasize infectious disease panels such as 87502 (influenza) and 87651 (Strep A). Complementary lines—lipid testing (80061), A1C (83036), vitamin D (82306) and molecular COVID testing (U0004)—show a full-service outpatient lab footprint rather than a narrow specialty niche.
Medicare revenue concentration is significant: the top three Medicare codes account for 34.2% of Medicare revenue, led by 80053 ($218.2K), 85025 ($169.6K) and 84443 ($164.8K). This concentration around high-volume routine panels and endocrine testing indicates core revenue dependence on standard outpatient diagnostics used across primary care and chronic disease management.
Medicaid revenue is similarly concentrated: the top three Medicaid codes account for 33.0% of Medicaid revenue, driven by infectious-disease molecular assays 87502 ($135.3K), 87651 ($117.7K) and U0004 ($81.1K). The Medicaid mix shows a heavier reliance on respiratory and STI nucleic-acid testing relative to Medicare, suggesting the provider captures substantial public-health testing demand in-state.
On competitive standing for Medicare, the provider routinely ranks at or near the top national percentiles on many routine assays—85025 ranks #121 of 32833 (100th percentile; notably above typical national volume), 36415 ranks #105 of 86467 (100th percentile; notably above typical national volume), and 80048 ranks #106 of 14725 (99th percentile; notably above typical national volume). These placements indicate a large national-scale throughput for common lab tests rather than a small regional operator.
In the Medicaid market the provider is a state-level leader for specific infectious-disease tests: 87651 ranks #1 of 71 providers in-state (100th percentile; extreme outlier) and 87502 ranks #2 of 84 providers in-state (99th percentile; extreme outlier). These rankings characterize LABCORP KANSAS, INC. as a dominant in-state supplier for Strep A and multi-target influenza molecular testing.
Operational and specimen-collection activity is prominent: Medicare claims include 40K for P9603 (travel allowance) with $40K revenue and 5.2K claims for G0471 ($25.8K revenue), while 36415 shows 25.7K claims ($128.7K revenue). The combination of high venipuncture counts and large P9603 activity implies a logistics-forward model with substantial outreach or nursing-home/homebound specimen collection.
The provider’s NPI was enumerated on 2022-04-27 (~4 years ago), indicating relatively recent enrollment; achieving multi-million-dollar lifetime revenues across Medicare and Medicaid in that interval suggests rapid scale-up of throughput and market penetration rather than long-established, slowly grown volume. This timeline, combined with the code-level rankings, supports an interpretation of fast operational expansion in both routine outpatient testing and state-level infectious-disease services.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
246 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 21,820 | $10 | $218.2K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 21,210 | $10 | $169.6K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 10,300 | $20 | $164.8K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 11,440 | $10 | $148.7K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 25,750 | $10 | $128.7K |
| 83036 | Sugar in the bloodstream can get attached to the hemoglobin in red blood cells. Once the sugar is attached, it stays there for the lifetime of the red blood cell (around 120 days or over 3 months).… | 9,850 | $10 | $98.5K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 3,150 | $30 | $91.3K |
| 83970 | Parathyroid hormone test measures the level of PTH in the blood. This test is done to ascertain the level of calcium and evaluate the parathyroid function. | 2,110 | $40 | $84.3K |
| 80048 | The lab analyst performs a basic metabolic pane (BMP) test in which he measures the blood level of eight chemicals including total calcium, sodium, potassium, chloride, carbon dioxide, glucose, blood… | 7,620 | $10 | $61K |
| 87086 | Culture, bacterial; quantitative, colony count, urine. | 5,440 | $10 | $43.5K |
Showing 1–10 of 246
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 246 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
246 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| G0480 | 4 | 10 | 140 | $110 | $160.3K |
| G0471 | 2 | 10 | 16,640 | $10 | $158.4K |
| 86480 | 3 | 10 | 540 | $60 | $105.6K |
| G0472 | 3 | 10 | 1,080 | $50 | $99.9K |
| 83521 | 4 | 10 | 1,580 | $20 | $83.5K |
| 86003 | 4 | 10 | 2,870 | $10 | $69.7K |
| 80307 | 7 | 20 | 220 | $60 | $46.9K |
| 84402 | 5 | 10 | 240 | $20 | $46.6K |
| 83970 | 3 | 40 | 30 | $40 | $45.5K |
| 80197 | 4 | 10 | 630 | $10 | $44.1K |
Showing 1–10 of 246
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
139 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 87502 | The lab analyst performs a test to determine the presence of multiple types or subtypes of influenza virus through nucleic acid detection using multiplex amplified probe technique and possibly… | 3,220 | $40 | $135.3K |
| 87651 | The lab analyst performs a test for the bacteria Streptococcus, group A, using amplified nucleic acid probe technique. Strep A commonly causes acute pharyngitis, or strep throat. | 7,360 | $20 | $117.7K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by… | 2,190 | $40 | $81.1K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 3,220 | $20 | $67.6K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 3,210 | $20 | $67.5K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 9,500 | $10 | $57K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 17,750 | $1 | $53.3K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 22,510 | $1 | $45K |
| 87635 | Using an amplified nucleic acid probe technique, the lab analyst performs the necessary steps to identify the nucleic acids from the severe acute respiratory syndrome coronavirus 2 (SARS–COV–2) virus… | 1,080 | $40 | $37.7K |
| 87086 | Culture, bacterial; quantitative, colony count, urine. | 8,500 | $1 | $34K |
Showing 1–10 of 139
How this provider's Medicaid billing volume and revenue compare to other Kansas providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Kansas median
139 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 4 | 10 | 140 | $40 | $854.5K |
| 86480 | The lab analyst performs a test to evaluate a cell mediated immunity gamma interferon antigen response to certain tuberculosis, or TB, antibodies. | 4 | 10 | 430 | $50 | $478.6K |
| 83013 | The lab analyst tests multiple breath samples for the presence of an isotope that indicates the presence of the H. pylori bacteria. This organism can cause irritation and ulcers of the stomach lining. | 3 | 10 | 550 | $50 | $468K |
| 86003 | The lab analyst performs the technical lab test to analyze a specimen such as serum for allergen–specific immunoglobulin E (IgE), using a crude allergen extract. The test result is quantitative or… | 4 | 10 | 1,000 | $50 | $385.6K |
| 87389 | The lab analyst performs a test to screen for human immunodeficiency virus, called HIV. The test screens for antigens of the HIV 1 virus and antibodies to the HIV 1 and HIV 2 viruses using an… | 7 | 20 | 120 | $20 | $375.6K |
| 87801 | The lab analyst performs a test for multiple infectious agents using amplified nucleic acid probe technique. | 5 | 10 | 620 | $40 | $354.6K |
| 80074 | The lab analyst performs an acute hepatitis panel; the panel must include tests for hepatitis A IgM antibody, hepatitis B core IgM antibody, hepatitis B surface antigen, and hepatitis C antibody. | 4 | 10 | 430 | $40 | $317.7K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 8 | 60 | 280 | $30 | $295.1K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 8 | 60 | 230 | $30 | $292K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by… | 2 | 10 | 1,580 | $50 | $246.8K |
Showing 1–10 of 139
Other providers in the same ZIP code as Labcorp Kansas, Inc., ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.